BeStock  
Stocks › Biotechnology › CGEM

Cullinan Therapeutics CGEM

US equityMarket cap rank #3511Biotechnology
$8.89 −$0.18 (-1.98%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $8.96 +0.79%
Open$8.84
Prev close$9.07
Day range$8.80 – $9.46
Volume1.01M
Market cap$577.15M
P/E (TTM)–
Dividend yield–

CGEM Stock News

Headlines matching Cullinan Therapeutics or the CGEM ticker, most recent first.

  • H.C. Wainwright Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $35 PositiveMarket news · 26 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Cullinan Therapeutics(CGEM.US), With a Forecast Between $33 to $40Market news · 25 Sep 2026 · Direct mention
  • Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $42 PositiveMarket news · 16 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Cullinan Therapeutics(CGEM.US), With a Forecast Between $30 to $42Market news · 15 Sep 2026 · Direct mention
  • JonesTrading Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $36Market news · 14 Sep 2026 · Direct mention
  • Morgan Stanley Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $30Market news · 17 Aug 2026 · Direct mention
  • UBS Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $27 PositiveMarket news · 17 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $30Market news · 17 Aug 2026 · Direct mention
  • Clear Street Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $47Market news · 15 Aug 2026 · Direct mention
  • Stifel Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $28Market news · 14 Aug 2026 · Direct mention
  • Clear Street Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $47 PositiveMarket news · 13 Aug 2026 · Direct mention
  • BTIG Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $39Market news · 29 Jul 2026 · Direct mention
  • BTIG Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Raises Target Price to $39 PositiveMarket news · 29 Jul 2026 · Direct mention
  • Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $37Market news · 29 Jul 2026 · Direct mention
  • Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $42Market news · 9 Nov 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on CGEM.

Sign in to join the discussion.

Scroll to Top